DRKS00024028已完成未知
Antiseptic gargle in COVID-19
niversitätsmedizin Rostock0 个研究点目标入组 152 人开始时间: 2021年2月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 152
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 110 Years（—）
- 性别
- All
入选标准
- •Hospital admission at University Hospital Rostock and positive SARS-CoV-2 PCR (specimen from oropharyngeal swab), consent to participate
排除标准
- •Pregnancy, past or current alcohol dependence, intolerance of chlorhexidine
研究者
相似试验
尚未招募
2 期
se of Steroid inhalers in COVID.CTRI/2021/05/033817YOU BREATHE WE CARE
招募中
不适用
Intranasal LMWH against COVID-19COVID-19NL-OMON28133ZonMW34
进行中（未招募）
1 期
Chemoprophylaxis of SARS-CoV-2 infection (COVID-19) in exposed healthcare workers: a randomized double-blind placebo-controlled clinical trialHealthcare workersMedDRA version: 21.1Level: LLTClassification code 10008434Term: Chemoprophylaxis NOSSystem Organ Class: 100000004865MedDRA version: 20.0Level: LLTClassification code 10061986Term: SARSSystem Organ Class: 100000004862EUCTR2020-001188-96-FRCHU de Saint Etienne1,200
尚未招募
4 期
Rheum and Pharyngitis Oral Solution for mild COVID-19 patients with the syndrome of damp-heat accumulation in the lung pattern: A randomized, double-blind, double-dummy, positive drug parallel controlled studyCOVID-19ITMCTR2200005905Guangdong Provincial Hospital of Chinese Medicine
进行中（未招募）
1 期
Hydroxychloroquine as a treatment for coronavirus disease COVID-19EUCTR2020-000890-25-FRFondation Méditerranée Infection (FMI) - IHU Méditerranée Infection25